Petros Pharmaceuticals, Inc.
PTPI
$0.031
-$0.0006-1.90%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.50% | -3,014.33% | 51.19% | 74.01% | -56.14% |
| Total Depreciation and Amortization | -- | -20.29% | -10.69% | -12.17% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.45% | 242.47% | -109.98% | -64,282.61% | 365.99% |
| Change in Net Operating Assets | -1,088.55% | 27.77% | 146.03% | -125.05% | 103.78% |
| Cash from Operations | -46.29% | 142.72% | 80.94% | -190.58% | -51.63% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -4.58% | -4.57% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | 42.73% | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 876.44% | 51.76% | -118.97% | -439.18% | -213.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 412.32% | 96.01% | -133.68% | -287.12% | -103.97% |